A critical role of luteolin-induced reactive oxygen species in blockage of tumor necrosis factor-activated nuclear factor-κB pathway and sensitization of apoptosis in lung cancer cells

被引:121
作者
Ju, Wei
Wang, Xia
Shi, Honglian
Chen, Wenshu
Belinsky, Steven A.
Lin, Yong
机构
[1] Lovelace Respiratory Res Inst, Mol Biol & Lung Canc Program, Albuquerque, NM 87108 USA
[2] Univ New Mexico, Coll Pharm, Albuquerque, NM 87131 USA
关键词
D O I
10.1124/mol.106.032185
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nuclear factor kappa B (NF-kappa B) activated by tumor necrosis factor (TNF) attenuates the TNF-induced apoptosis pathway. Therefore, blockage of NF-kappa B should improve the anticancer activity of TNF. Luteolin, a naturally occurring polyphenol flavonoid, has been reported to sensitize colorectal cancer cells to TNF-induced apoptosis through suppression of NF-kappa B; however, the mechanisms of this effect have not been well elucidated. In this article, we provide evidence showing a critical role of reactive oxygen species (ROS) accumulation induced by luteolin in modulating TNF-activated pathways in lung cancer cells. Luteolin effectively suppressed NF-kappa B, whereas it potentiated the c-Jun N-terminal kinase (JNK) to increase apoptosis induced by TNF in lung cancer cells. Our results further demonstrate that luteolin induced an early phase ROS accumulation via suppression of the cellular superoxide dismutase activity. It is noteworthy that suppression of ROS accumulation by ROS scavengers butylated hydroxyanisole, and N-acetyl-L-cysteine prevented the luteolin-induced suppression of NF-kappa B and potentiation of JNK and significantly suppressed the synergistic cytotoxicity seen with cotreatment of luteolin and TNF. Taken together, these results suggest that the accumulation of ROS induced by luteolin plays a pivotal role in suppression of NF-kappa B and potentiation of JNK to sensitize lung cancer cells to undergo TNF-induced apoptosis.
引用
收藏
页码:1381 / 1388
页数:8
相关论文
共 40 条
[1]   Signalling pathways of the TNF superfamily: A double-edged sword [J].
Aggarwal, BB .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (09) :745-756
[2]   Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3'-kinase activity [J].
Bagli, E ;
Stefaniotou, M ;
Morbidelli, L ;
Ziche, M ;
Psillas, K ;
Murphy, C ;
Fotsis, T .
CANCER RESEARCH, 2004, 64 (21) :7936-7946
[3]   Tnfa and Il-10 deficiencies have contrasting effects on lung tumor susceptibility:: Gender-dependent modulation of IL-10 haploinsufficiency [J].
Bernert, H ;
Sekikawa, K ;
Radcliffe, RA ;
Iraqi, F ;
You, M ;
Malkinson, AM .
MOLECULAR CARCINOGENESIS, 2003, 38 (03) :117-123
[4]   The copper chaperone for superoxide dismutase [J].
Culotta, VC ;
Klomp, LWJ ;
Strain, J ;
Casareno, RLB ;
Krems, B ;
Gitlin, JD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (38) :23469-23472
[5]   Regulation and measurement of oxidative stress in apoptosis [J].
Curtin, JF ;
Donovan, M ;
Cotter, TG .
JOURNAL OF IMMUNOLOGICAL METHODS, 2002, 265 (1-2) :49-72
[6]   The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation [J].
Devin, A ;
Cook, A ;
Lin, Y ;
Rodriguez, Y ;
Kelliher, M ;
Liu, ZG .
IMMUNITY, 2000, 12 (04) :419-429
[7]   Reactive oxygen species promote TNFα-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases [J].
Kamata, H ;
Honda, S ;
Maeda, S ;
Chang, LF ;
Hirata, H ;
Karin, M .
CELL, 2005, 120 (05) :649-661
[8]  
Kanadaswami C, 2005, IN VIVO, V19, P895
[9]   The IKKNF-κB system:: A treasure trove for drug development [J].
Karin, M ;
Yamamoto, Y ;
Wang, QM .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (01) :17-26
[10]   Luteolin inhibits the nuclear factor-κB transcriptional activity in Rat-1 fibroblasts [J].
Kim, SH ;
Shin, KJ ;
Kim, D ;
Kim, YH ;
Han, MS ;
Lee, TG ;
Kim, E ;
Ryu, SH ;
Suh, PG .
BIOCHEMICAL PHARMACOLOGY, 2003, 66 (06) :955-963